Alcista
$3.66
Precio del escenario
$4.790
-0.020 (-0.42%)Al cierre
Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states.
Clover Health Investments Corp is a good buy right now due to its recent performance and positive market indicators. The current price is $4.79, and the stock has seen a year-to-date change of +98.76%, indicating strong momentum. Additionally, the RSI is at 71.449, suggesting that the stock is in a strong bullish trend. The forward P/E ratio is 37.7358, which, while high, reflects growth potential in the expanding Medicare Advantage market. The main risk is the high volatility indicated by an implied volatility of 85.65%, which could lead to significant price fluctuations.
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Medicare Star Ratings Shift Impacts Stock Prices

Alignment Healthcare Shares Plunge 22% Amidst Overhaul Challenges

Humana's 2026 Profit Expected to Drop by $3.5 Billion

Latest Wall Street Ratings Overview

Clover Health (CLOV) Q2 2026 Earnings Call Transcript
Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).
Clover Health Investments Corp is a good buy right now due to its recent performance and positive market indicators. The current price is $4.79, and the stock has seen a year-to-date change of +98.76%, indicating strong momentum. Additionally, the RSI is at 71.449, suggesting that the stock is in a strong bullish trend. The forward P/E ratio is 37.7358, which, while high, reflects growth potential in the expanding Medicare Advantage market. The main risk is the high volatility indicated by an implied volatility of 85.65%, which could lead to significant price fluctuations.

HUM Stock Soars, ALHC Sinks As CMS Star Ratings Redraw 2028 Bonuses $HUM $ALHC $CLOV $CVS
Mostrar másEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.